Norepinephrine vs dobutamine interventional study therapy in patients with acute cardiogenic shock: preliminary results of nordist randomized clinical trial

Back

ESC2025 Premium Access

Norepinephrine vs dobutamine interventional study therapy in patients with acute cardiogenic shock: preliminary results of nordist randomized clinical trial

Session: Cardiogenic shock in acute heart failure

Topic: Cardiogenic Shock

Speaker: Doctor P. Baratta (Grosseto, IT)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Pasquale Baratta

Misericordia Hospital, Grosseto (Italy)

0 follower

7 more presentations in this session

Balancing blood pressure and catecholamine support is critical in cardiogenic shock patients

Speaker: Doctor B. Beer (Stockholm, SE)

Real-world long-term one-centre experience with the use of 113 fully magnetically levitated continuous flow left ventricular assist devices

Speaker: Doctor A. Bielka (Zabrze, PL)

Examination of the usefulness of our original clinical pathway for acute care of congestive heart failure aiming to improve short and long-term clinical prognosis

Speaker: Mr T. Suyama (Kanonji, JP)

Endomyocardial biopsy in cardiogenic Shock: experience from a contemporary CICU portuguese cohort

Speaker: Doctor D. Da Silva Correia (Lisbon, PT)

Impact and safety of remote monitoring of heart failure patients managed with the Heartlogic Algorithm: The Heartlogic France Cohort study

Speaker: Professor R. Garcia (Poitiers, FR)

Access the full session

Cardiogenic shock in acute heart failure

Speakers: Doctor P. Baratta, Doctor B. Beer, Doctor A. Bielka, Mr T. Suyama, Doctor D. Da Silva Correia...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources